SLB
55
2
STI
14
-17
GIS
31
3
CTSH
56
2
PLD
56
8
SWK
64
5
AXP
71
2
BSX
67
-3
LH
43
-2
ORCL
65
-2
MLM
57
6
CMG
72
5
AMG
54
2
M
37
12
MAS
58
2
WDC
47
4
SIG
52
3
URI
65
5
NKE
36
6
PAYX
53
2
SLB
55
2
STI
14
-17
GIS
31
3
CTSH
56
2
PLD
56
8
SWK
64
5
AXP
71
2
BSX
67
-3
LH
43
-2
ORCL
65
-2
MLM
57
6
CMG
72
5
AMG
54
2
M
37
12
MAS
58
2
WDC
47
4
SIG
52
3
URI
65
5
NKE
36
6
PAYX
53
2
Financhill
Back

Global X Genomics & Biotechnology ETF Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

GNOM
Global X Genomics & Biotechnology ETF

Last Price:
10.09
Seasonality Move:
5.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Global X Genomics & Biotechnology ETF Stock Forecast

  • Over the next 52 weeks, Global X Genomics & Biotechnology ETF has on average historically fallen by 4.3% based on the past 5 years of stock performance.
  • Global X Genomics & Biotechnology ETF has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Global X Genomics & Biotechnology ETF Stock Undervalued?
    The current Global X Genomics & Biotechnology ETF [GNOM] share price is $10.08. The Score for GNOM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • GNOM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Global X Genomics & Biotechnology ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Global X Genomics & Biotechnology ETF has on average historically fallen by 4.3% based on the past 5 years of stock performance.

Global X Genomics & Biotechnology ETF Stock Rating

Sell
45
Global X Genomics & Biotechnology ETF (GNOM) is a Sell

Is Global X Genomics & Biotechnology ETF overpriced?

  • Global X Genomics & Biotechnology ETF has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Global X Genomics & Biotechnology ETF Stock Price History

Is GNOM stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNOM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
12.53
52-Week Low:
9.52

Prediction Charts

Market Cap:
0
Price in USD:
10.08
Volume:
38.33K
Beta:
1.18

Technical Analysis

SMA50:
10.75
SMA100:
10.98
SMA200:
10.91
52-Wk Change:
-3.59%

Stock Predictions

  • Is Global X Genomics & Biotechnology ETF stock public?
    Yes, Global X Genomics & Biotechnology ETF is a publicly traded company.
  • What is the Global X Genomics & Biotechnology ETF stock quote today?
    The Global X Genomics & Biotechnology ETF stock price is 10.08 USD today.
  • How to buy Global X Genomics & Biotechnology ETF stock online?
    You can buy Global X Genomics & Biotechnology ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 10.56 10.69 10.71 10.47
Nov-6 10.93 10.79 10.93 10.68
Nov-7 10.92 10.86 11.01 10.80
Nov-8 10.84 10.77 10.84 10.69
Nov-11 10.87 10.89 11.09 10.87
Nov-12 10.81 10.57 10.83 10.53
Nov-13 10.68 10.60 10.84 10.60
Nov-14 10.62 10.20 10.65 10.20
Nov-15 10.20 9.65 10.20 9.65
Nov-18 9.74 9.62 9.74 9.55
Nov-19 9.57 9.76 9.76 9.52
Nov-20 9.76 9.82 9.83 9.65
Nov-21 9.74 9.83 9.93 9.69
Nov-22 9.86 10.08 10.09 9.81

Global X Genomics & Biotechnology ETF Earnings

Data Unavailable

Global X Genomics & Biotechnology ETF Forecast Revenue Growth

Data Unavailable

* Global X Genomics & Biotechnology ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.